Patrick Mismetti

7.9k total citations · 2 hit papers
154 papers, 4.2k citations indexed

About

Patrick Mismetti is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Patrick Mismetti has authored 154 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Internal Medicine, 88 papers in Cardiology and Cardiovascular Medicine and 32 papers in Surgery. Recurrent topics in Patrick Mismetti's work include Venous Thromboembolism Diagnosis and Management (105 papers), Atrial Fibrillation Management and Outcomes (61 papers) and Central Venous Catheters and Hemodialysis (22 papers). Patrick Mismetti is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (105 papers), Atrial Fibrillation Management and Outcomes (61 papers) and Central Venous Catheters and Hemodialysis (22 papers). Patrick Mismetti collaborates with scholars based in France, United States and Canada. Patrick Mismetti's co-authors include Silvy Laporte, Hervé Decousus, Laurent Bertoletti, Xavier Delavenne, Manuel Monréal, Remedios Otero, José Luís Lobo, Fernando Uresandi, Céline Chapelle and Ajay K. Kakkar and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Patrick Mismetti

139 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism

2008 469 citations Silvy Laporte, Patrick Mismetti et al. Circulation profile →
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

2012 382 citations Ajay K. Kakkar, Winfield S. Fisher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Mismetti France	33	2.9k	2.2k	1.0k	843	628	154	4.2k
Dominique Mottier France	33	3.5k 1.2×	2.8k 1.2×	1.3k 1.2×	483 0.6×	1.2k 1.8×	143	5.5k
Geno J. Merli United States	37	4.8k 1.7×	3.8k 1.7×	1.7k 1.6×	935 1.1×	723 1.2×	155	6.3k
Mashio Nakamura Japan	28	2.6k 0.9×	2.2k 1.0×	851 0.8×	479 0.6×	398 0.6×	151	3.6k
Patrick Mismetti France	31	5.2k 1.8×	4.6k 2.1×	1.8k 1.7×	692 0.8×	1.1k 1.7×	118	6.8k
Silvy Laporte France	33	3.7k 1.3×	2.6k 1.2×	1.7k 1.6×	1.1k 1.4×	553 0.9×	144	5.3k
Gregory Piazza United States	33	2.5k 0.9×	1.6k 0.7×	1.1k 1.1×	397 0.5×	365 0.6×	160	4.0k
Marco Moia Italy	37	3.4k 1.2×	2.8k 1.2×	1.4k 1.3×	806 1.0×	1.5k 2.5×	101	5.9k
Henry Eriksson Sweden	23	4.5k 1.6×	4.6k 2.1×	1.1k 1.1×	491 0.6×	1.1k 1.7×	46	5.8k
Alejandro Lazo‐Langner Canada	29	1.6k 0.6×	1.0k 0.5×	588 0.6×	372 0.4×	696 1.1×	169	3.2k
Michael Gould Australia	18	3.8k 1.3×	2.9k 1.3×	1.7k 1.6×	786 0.9×	680 1.1×	45	6.0k

Countries citing papers authored by Patrick Mismetti

Since Specialization

Citations

This map shows the geographic impact of Patrick Mismetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Mismetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Mismetti more than expected).

Fields of papers citing papers by Patrick Mismetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Mismetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Mismetti. The network helps show where Patrick Mismetti may publish in the future.

Co-authorship network of co-authors of Patrick Mismetti

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Mismetti. A scholar is included among the top collaborators of Patrick Mismetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Mismetti. Patrick Mismetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2024). Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer ». La Revue de Médecine Interne. 45(4). 210–225. 2 indexed citations

Mismetti, Patrick, et al.. (2024). Elderly patients with venous thromboembolism: Insights from the RIETE registry. La Presse Médicale. 53(4). 104246–104246. 2 indexed citations

Poénou, Géraldine, et al.. (2024). Latest advances in the reversal strategies for direct oral anticoagulants. Fundamental and Clinical Pharmacology. 38(4). 674–684. 2 indexed citations

Couturaud, Françis, Olivier Sanchez, Nicolas Méneveau, et al.. (2024). Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence. Blood. 144(Supplement 2). LBA–3. 1 indexed citations

Pernod, Gilles, Ariel Cohen, Patrick Mismetti, Olivier Sanchez, & Isabelle Mahé. (2023). Cancer-related arterial thromboembolic events. Archives of cardiovascular diseases. 117(1). 101–113. 5 indexed citations

Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2023). Anticoagulant treatment of cancer-associated thromboembolism. Archives of cardiovascular diseases. 117(1). 29–44. 8 indexed citations

Poénou, Géraldine, Marco Heestermans, Ludovic Lafaie, et al.. (2023). Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?. International Journal of Molecular Sciences. 24(19). 14433–14433. 6 indexed citations

Roy, Pierre‐Marie, Raphaël Le Mao, Frédéric Gagnadoux, et al.. (2023). OC 11.2 Pulmonary Embolism Diagnostic Strategies in Patients with COPD Exacerbation: Post-Hoc Analysis of the Pep Trial. Research and Practice in Thrombosis and Haemostasis. 7. 100630–100630. 1 indexed citations

Douillet, Delphine, Céline Chapelle, Édouard Ollier, et al.. (2022). Prevention of venous thromboembolic events in patients with lower leg immobilization after trauma: Systematic review and network meta-analysis with meta-epsidemiological approach. PLoS Medicine. 19(7). e1004059–e1004059. 10 indexed citations

10.

Hamzeh‐Cognasse, Hind, Alexandre Mansour, Florian Reizine, et al.. (2021). Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection. Virology Journal. 18(1). 211–211. 19 indexed citations

11.

Schulman, Sam, Henry Eriksson, Samuel Z. Goldhaber, et al.. (2014). Abstract 18594: Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER™ and RE-COVER™ II. Circulation. 130. 4 indexed citations

12.

Lega, Jean‐Christophe, et al.. (2013). Consistency of safety profile of new oral anticoagulants in patients with renal failure. Journal of Thrombosis and Haemostasis. 12(3). 337–343. 28 indexed citations

13.

Lassen, Michael R., Winfield S. Fisher, Patrick Mouret, et al.. (2012). Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE. Journal of Thrombosis and Haemostasis. 10(5). 822–832. 20 indexed citations

14.

Decousus, Hervé, I. Quéré, Émilie Presles, et al.. (2010). Superficial Venous Thrombosis and Venous Thromboembolism. Annals of Internal Medicine. 6 indexed citations

15.

Debourdeau, P., Grégoire Le Gal, Irène Kriegel, et al.. (2009). 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Annals of Oncology. 20(9). 1459–1471. 95 indexed citations

16.

Mismetti, Patrick. (2008). Essai randomisé évaluant l’efficacité d’une interruption partielle de la veine cave inférieure par un filtre cave optionnel sur la prévention des récidives d’embolies pulmonaires. Étude PREPIC 2 : prévention des récidives emboliques par interruption cave (étude prospective, multicentrique, randomisée, en ouvert). Revue de Pneumologie Clinique. 64(6). 328–331. 18 indexed citations

17.

Mismetti, Patrick, et al.. (2007). Abstract. Journal of Thrombosis and Haemostasis. 5. SYM–S1. 1 indexed citations

18.

Mismetti, Patrick, Silvy Laporte, & Michel Cucherat. (2007). Les essais de non-infériorité. 13(4). 304–310. 1 indexed citations

19.

Pouchain, Denis, Jean‐François Bergmann, Yves Gruel, et al.. (2007). Prévention de la maladie thromboembolique veineuse chez les patients médicaux : où en est-on ?. Sang thrombose vaisseaux. 19(2). 76–84.

20.

Mismetti, Patrick & Ludovic Drouet. (2004). Critères d‘efficacité dans les essais de thromboprophylaxie : intérêt et pertinence clinique des thromboses veineuses asymptomatiques. Sang thrombose vaisseaux. 16(1). 16–23. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact